tert-Butyl 3-(prop-2-yn-1-yl)azetidine-1-carboxylate

Catalog No. :
ACBXPN307
CAS No. :
1463502-41-1
Molecular Formula :
C11H17NO2
Molecular Weight :
195.26

IUPAC Name:tert-butyl 3-(prop-2-yn-1-yl)azetidine-1-carboxylate

tert-Butyl 3-(prop-2-yn-1-yl)azetidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$56.00Login to see priceIn stockInquiry
250mg98%$107.00Login to see priceIn stockInquiry
1g98%$264.00Login to see priceIn stockInquiry
5g98%$1014.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 3-(prop-2-yn-1-yl)azetidine-1-carboxylate
IUPAC Nametert-butyl 3-(prop-2-yn-1-yl)azetidine-1-carboxylate
MDL No.MFCD32173212
Molecular FormulaC11H17NO2
Molecular Weight195.26
SMILESO=C(N1CC(CC#C)C1)OC(C)(C)C
InChI KeyZNCUKMXOJHHWHJ-UHFFFAOYSA-N
SynonymEN300-1893966 | AKOS040804005 | SY293147 | PB48353 | tert-Butyl 3-(prop-2-yn-1-yl)azetidine-1-carboxylate | BS-46481 | SCHEMBL15295758 | AT11968 | 1463502-41-1 | CS-0132032 | 1-Boc-3-(2-propynyl)azetidine | tert-butyl 3-prop-2-ynylazetidine-1-carboxylate
CAS No.1463502-41-1
PubChem CID89832936

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACBXPN307 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBXPN307 route product structure diagram
    ACBXPN3071463502-41-1 In Stock
Inquiry

2. ACBXPN307 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBXPN307 route product structure diagram
    ACBXPN3071463502-41-1 In Stock
Inquiry

Comments (0)